Sigrid S. Skånland PhD

Project group leader and lab leader at Oslo University Hospital

Sigrid S. Skånland received her PhD from the Faculty of Mathematics and Natural Sciences at University of Oslo in 2009, under the supervision of Prof. Kirsten Sandvig. She was then awarded with a long-term EMBO fellowship to do her post-doctoral training in the Molecular Signaling Group of Prof. Ivan Dikic (2009-2011) at the University Hospital Frankfurt, Germany.

From 2011, Skånland has been affiliated with the research group of Prof. Kjetil Taskén, first at the Nordic EMBL Partnership for Molecular Medicine in Norway (NCMM), currently at Oslo University Hospital. Here, she has established her own research group focusing on functional precision medicine in haematologic cancers, in particular the B-cell malignancy chronic lymphocytic leukemia. By performing functional analyses including ex vivo drug sensitivity screening and single cell signaling analyses, her aim is to identify biomarker signatures that can predict treatment outcomes for the individual patient.

In 2020, Skånland was awarded a prestigious European Commission ERA PerMed research grant on tailoring the targeted treatment of chronic lymphocytic leukemia.

Scroll to Top